Format

Send to

Choose Destination
J Anxiety Disord. 2013 Dec;27(8):793-801. doi: 10.1016/j.janxdis.2013.03.005. Epub 2013 Apr 1.

Direct-to-consumer marketing of psychological treatments for anxiety disorders.

Author information

1
Boston University, Department of Psychology, Center for Anxiety and Related Disorders, 648 Beacon Street, 6th Floor, Boston, MA 02215, USA. Electronic address: kgallo@post.harvard.edu.

Abstract

Progress disseminating and implementing evidence-based psychological treatments (EBPTs) for the anxiety disorders has been gradual. To date, the dominant approach for promoting the uptake of EBPTs in clinical settings has been to target the education and training of mental health providers, with many consumers remaining unaware of the potential benefits of EBPTs for anxiety disorders. Direct-to-consumer (DTC) marketing may be a promising vehicle for increasing EBPT utilization rates in the treatment of anxiety disorders. This paper provides an overview of the rationale and important considerations for applying DTC efforts to promote evidence-based care in the treatment of anxiety disorders, and reviews current DTC efforts in this area, including resources on the Internet and other media and in-person events. We conclude with recommendations for future efforts in the DTC marketing of EBPTs for the anxiety disorders, including the need for increased funding and grassroots efforts to inform consumers about anxiety disorders and their most effective treatments.

KEYWORDS:

Anxiety disorders; Dissemination; Evidence-based psychological treatments; Implementation

PMID:
23602058
DOI:
10.1016/j.janxdis.2013.03.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center